Novartis AG (NVS)
160.06
+1.86
(+1.18%)
USD |
NYSE |
Feb 11, 16:00
160.35
+0.29
(+0.18%)
After-Hours: 20:00
Novartis Market Cap : 305.42B for Feb. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Roche Holding AG | 368.15B |
| Amgen, Inc. | 197.59B |
| AstraZeneca PLC | 634.87B |
| Gilead Sciences, Inc. | 193.35B |
| Regeneron Pharmaceuticals, Inc. | 82.35B |
Market Cap Related Metrics
| PE Ratio | 22.28 |
| PS Ratio | 5.709 |
| PEG Ratio | 0.9879 |
| Price to Book Value | 6.621 |
| Price to Free Cash Flow | 20.39 |
| Price | 160.06 |
| Earnings Yield | 4.49% |
| PEGY Ratio | 0.8895 |
| Operating PE Ratio | 18.32 |
| Normalized PE Ratio | 21.18 |